A report in the Feb. 13 New England Journal of Medicine confirms previous studies suggesting that long-term treatment with the type of drugs commonly prescribed to treat restless leg syndrome (RLS) can cause a serious worsening ...
Feb 13, 2014
0
0
"Sleep is the best medicine," says the old proverb. But many adults don't benefit enough from sleep, with as many as 60 percent reporting sleep problems at least several nights a week.
Jul 24, 2013
0
0
Men who experience restless legs syndrome (RLS) may have a higher risk of dying earlier, according to research that appears in the June 12, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology. ...
Jun 12, 2013
0
0
A protein profile of people with restless leg syndrome (RLS), identifies factors behind disrupted sleep, cardiovascular dysfunction and pain finds research in BioMed Central's open access journal Fluids and Barriers of the ...
Jun 6, 2013
0
0
The issue of sleep deprivation has gone beyond the counting of sheep and into the scientific domain, as European researchers set up 'sleep labs' to study the biomedical and sociological factors keeping us awake at night.
May 3, 2013
0
0
(HealthDay)—People suffering from restless legs syndrome may find some relief by taking one of several drugs approved to treat the condition, a new review confirms.
Mar 4, 2013
0
0
As fall semesters wind down at the country's colleges and universities, students will be pulling all-night study sessions to prepare for final exams. Ironically, the loss of sleep during these all-nighters could actually ...
Nov 26, 2012
0
0
(HealthDay)—People with insomnia may have double the chances of a heart attack or stroke as opposed to those who sleep well, a study by Taiwanese researchers suggests.
Nov 5, 2012
0
0
(Medical Xpress) -- A study by Wits researchers has come to the aid of health practitioners who have previously had difficulty in diagnosing one of the most common neurological, but difficult to describe conditions, Restless ...
May 31, 2012
0
0
(HealthDay) -- The Neupro (rotigotine) transdermal system has been approved by the U.S. Food and Drug Administration to treat advanced Parkinson's disease and moderate-to-severe restless leg syndrome, the Belgian drug maker ...
Apr 3, 2012
0
0
